20 Mar 20
20 Mar 20

Biocomposites Status on Novel Coronavirus (COVID-19)

The recent events and rise of the COVID-19 virus on a global scale have brought challenges to us in ways that were unimaginable at the beginning of the year. We have been following the guidance published by the governments in the countries that we operate in to keep our employees safe, whilst ensuring that we continue to manufacture our lifesaving products.

Our warehouses are stocked – including our newly opened facilities in the US and UK – and we have every confidence that we can continue to meet the needs of our distributors, hospital partners and their surgeons.

We are executing new site access guidelines to restrict visitors to our facilities and conducting a staff capability review across all functions to ensure we have cover in business-critical processes.

As always, we remain focused on supporting the wellbeing and safety of our staff and delivering our excellent products to patients and hospitals worldwide.

Thank you and best wishes through this period.

About Biocomposites

Biocomposites is an international medical device company that engineers, manufactures and markets world leading products for use in infection management in bone and soft tissue. Based in Keele, UK, it has global operations across Europe, USA, Canada, China and India. Biocomposites is a world leader in the development of innovative calcium compounds and polymers for surgical use. Its products regenerate bone and target infection risks across a variety of specialties, including musculoskeletal infection, orthopaedics, trauma, spine, foot and ankle, podiatry and sports injuries. Biocomposites products are now used in over 1 million procedures per annum and sold in more than 100 countries around the world. Please visit to learn more.

Other news

Listed below is a list of the 4 most recent news updates made by Biocomposties

Visit our News & Events page


Interested in other types of our content? See a list of some of our most recent below.

Explore Library